Cargando…
P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428697/ http://dx.doi.org/10.1097/01.HS9.0000969420.14325.17 |
| _version_ | 1785090531002417152 |
|---|---|
| author | Niemann, Carsten Levin, Mark-David Österborg, Anders Lundin, Jeanette Kättström, Magdalena Vollerup, Jeanette Da Cunha-Bang, Caspar Foraux, Michael Brieghel, Christian de Boer, Fransien Enggaard, Lisbeth Bjorn Poulsen, Christian Reekie, Joanne Agius, Rudi |
| author_facet | Niemann, Carsten Levin, Mark-David Österborg, Anders Lundin, Jeanette Kättström, Magdalena Vollerup, Jeanette Da Cunha-Bang, Caspar Foraux, Michael Brieghel, Christian de Boer, Fransien Enggaard, Lisbeth Bjorn Poulsen, Christian Reekie, Joanne Agius, Rudi |
| author_sort | Niemann, Carsten |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428697 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104286972023-08-17 P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL Niemann, Carsten Levin, Mark-David Österborg, Anders Lundin, Jeanette Kättström, Magdalena Vollerup, Jeanette Da Cunha-Bang, Caspar Foraux, Michael Brieghel, Christian de Boer, Fransien Enggaard, Lisbeth Bjorn Poulsen, Christian Reekie, Joanne Agius, Rudi Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428697/ http://dx.doi.org/10.1097/01.HS9.0000969420.14325.17 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Niemann, Carsten Levin, Mark-David Österborg, Anders Lundin, Jeanette Kättström, Magdalena Vollerup, Jeanette Da Cunha-Bang, Caspar Foraux, Michael Brieghel, Christian de Boer, Fransien Enggaard, Lisbeth Bjorn Poulsen, Christian Reekie, Joanne Agius, Rudi P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL |
| title | P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL |
| title_full | P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL |
| title_fullStr | P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL |
| title_full_unstemmed | P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL |
| title_short | P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL |
| title_sort | p629: the cll treatment infection model – clinical prospective validation as part of the prevent-acall trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428697/ http://dx.doi.org/10.1097/01.HS9.0000969420.14325.17 |
| work_keys_str_mv | AT niemanncarsten p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT levinmarkdavid p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT osterborganders p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT lundinjeanette p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT kattstrommagdalena p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT vollerupjeanette p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT dacunhabangcaspar p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT forauxmichael p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT brieghelchristian p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT deboerfransien p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT enggaardlisbeth p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT bjornpoulsenchristian p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT reekiejoanne p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial AT agiusrudi p629theclltreatmentinfectionmodelclinicalprospectivevalidationaspartofthepreventacalltrial |